home / stock / bmy / bmy news


BMY News and Press, Bristol-Myers Squibb Company From 04/25/24

Stock Information

Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Website: bms.com

Menu

BMY BMY Quote BMY Short BMY News BMY Articles BMY Message Board
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...

BMY - Bristol-Myers to cut 2,200 jobs as part of $1.5B cost saving plan

2024-04-25 10:08:18 ET More on Bristol-Myers Squibb Company Is Bristol Myers Squibb A Buy At These Bottom Levels? Bristol-Myers Squibb: Market Pessimism Won't Last Forever Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade) Bristol-...

BMY - US Companies Moving the Markets, Morning edition
Thu, Apr 25, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Safe & Green Holdings Corp. (SGBX) rose 52.1% to $0.2192 on volume of 34,842,044 shares Processa Pharmaceuticals Inc. (PCSA) rose 46.9% to $2.38 on volume of 31,858,013 shares PROSHARES TRUST (SQQQ) rose 5.0% to $12.4002 on volume...

BMY - Bristol-Myers posts Q1 beat despite growth headwinds

2024-04-25 07:56:55 ET More on Bristol-Myers Squibb Company Is Bristol Myers Squibb A Buy At These Bottom Levels? Bristol-Myers Squibb: Market Pessimism Won't Last Forever Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade) Bristol-...

BMY - Bristol-Myers in charts: Revenue from Eliquis rises, while Opdivo drops in Q1

2024-04-25 07:44:29 ET More on Bristol-Myers Squibb Company Is Bristol Myers Squibb A Buy At These Bottom Levels? Bristol-Myers Squibb: Market Pessimism Won't Last Forever Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade) Bris...

BMY - Bristol-Myers Squibb Company  Non-GAAP EPS of -$4.40 beats by $0.02, revenue of $11.78B beats by $330M

2024-04-25 07:01:03 ET More on Bristol-Myers Squibb Company Is Bristol Myers Squibb A Buy At These Bottom Levels? Bristol-Myers Squibb: Market Pessimism Won't Last Forever Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade) Bristol-...

BMY - Expected US Company Earnings on Thursday, April 25th, 2024

Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...

BMY - Bristol Myers Squibb Reports First Quarter Financial Results for 2024

Performance Reflects Execution and Actions to Strengthen the Company's Long-Term Growth Profile First Quarter Revenues were $11.9 Billion, increasing 5% (+6% Adjusting for Foreign Exchange) Growth Portfolio Revenues were $4.8 Billion, increasing 8% (+11% Adjusting for Foreign Ex...

BMY - Bristol-Myers Earnings Preview: Major near-term headwinds invites worries about Q1 results

2024-04-24 09:38:26 ET Bristol-Myers Squibb Company ( NYSE: BMY ) is scheduled to announce Q1 earnings results on Thursday, April 25th, before market open.... Read the full article on Seeking Alpha For further details see: Bristol-Myers Earnings Preview: Major n...

BMY - S&P 500 stocks with biggest estimated EPS declines for Q1

2024-04-23 12:33:52 ET Moderna ( NASDAQ: MRNA ), Ventas ( NYSE: VTR ) and American Airlines ( NASDAQ: AAL ) are among the S&P 500 companies with the greatest expected Y/Y decreases in EPS for the first quarter, according to the latest from S&P Globa...

BMY - Baron Health Care Fund Q1 2024 Shareholder Letter

2024-04-23 09:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared wi...

Previous 10 Next 10